KERYX BIOPHARMACEUTICALS INC Insider Trading for July 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in KERYX BIOPHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in KERYX BIOPHARMACEUTICALS INC for July 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 31 2018 | KERX | KERYX BIOPHARMACEU ... | Neylan John F. | Chief Medical Offic ... | Sell | S | 3.86 | 1,282 | 4,949 | 151,874 | 153.2 K to 151.9 K (-0.84 %) |
| Jul 31 2018 | KERX | KERYX BIOPHARMACEU ... | Holmes Scott A | Chief Financial Off ... | Sell | S | 3.86 | 2,354 | 9,086 | 166,550 | 168.9 K to 166.6 K (-1.39 %) |
| Jul 19 2018 | KERX | KERYX BIOPHARMACEU ... | Carberry Christine A. | Chief Operating Off ... | Sell | S | 4.49 | 2,021 | 9,074 | 113,155 | 115.2 K to 113.2 K (-1.75 %) |
| Jul 12 2018 | KERX | KERYX BIOPHARMACEU ... | Cameron Kevin J | Director | Option Exercise | A | 3.76 | 30,000 | 112,800 | 30,000 | |
| Jul 12 2018 | KERX | KERYX BIOPHARMACEU ... | Cameron Kevin J | Director | Grant | A | 0.00 | 10,000 | 0 | 186,666 | 176.7 K to 186.7 K (+5.66 %) |
| Jul 12 2018 | KERX | KERYX BIOPHARMACEU ... | GILMAN STEVEN C | Director | Option Exercise | A | 3.76 | 30,000 | 112,800 | 30,000 | |
| Jul 12 2018 | KERX | KERYX BIOPHARMACEU ... | GILMAN STEVEN C | Director | Grant | A | 0.00 | 10,000 | 0 | 27,333 | 17.3 K to 27.3 K (+57.69 %) |
| Jul 12 2018 | KERX | KERYX BIOPHARMACEU ... | ROGERS MICHAEL W | Director | Option Exercise | A | 3.76 | 30,000 | 112,800 | 30,000 | |
| Jul 12 2018 | KERX | KERYX BIOPHARMACEU ... | ROGERS MICHAEL W | Director | Grant | A | 0.00 | 10,000 | 0 | 30,000 | 20 K to 30 K (+50.00 %) |
| Jul 12 2018 | KERX | KERYX BIOPHARMACEU ... | Enyedy Mark J | Director | Option Exercise | A | 3.76 | 30,000 | 112,800 | 30,000 | |
| Jul 12 2018 | KERX | KERYX BIOPHARMACEU ... | Enyedy Mark J | Director | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Jul 12 2018 | KERX | KERYX BIOPHARMACEU ... | Morrison Jodie Pope | Interim CEO | Option Exercise | A | 3.76 | 30,000 | 112,800 | 30,000 | |
| Jul 12 2018 | KERX | KERYX BIOPHARMACEU ... | Morrison Jodie Pope | Interim CEO | Grant | A | 0.00 | 10,000 | 0 | 120,000 | 110 K to 120 K (+9.09 %) |
| Jul 12 2018 | KERX | KERYX BIOPHARMACEU ... | Regan Daniel Paul | Director | Option Exercise | A | 3.76 | 30,000 | 112,800 | 30,000 | |
| Jul 12 2018 | KERX | KERYX BIOPHARMACEU ... | Regan Daniel Paul | Director | Grant | A | 0.00 | 10,000 | 0 | 60,000 | 50 K to 60 K (+20.00 %) |
| Jul 12 2018 | KERX | KERYX BIOPHARMACEU ... | Heffernan Michael Thomas | Director | Option Exercise | A | 3.76 | 30,000 | 112,800 | 30,000 | |
| Jul 12 2018 | KERX | KERYX BIOPHARMACEU ... | Heffernan Michael Thomas | Director | Grant | A | 0.00 | 10,000 | 0 | 20,000 | 10 K to 20 K (+100.00 %) |